- Home
- GNLX vs ALCYU Comparison
GNLX vs ALCYU Comparison
Compare GNLX & ALCYU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNLX
- ALCYU
- Stock Information
- Founded
- GNLX 2001
- ALCYU N/A
- Country
- GNLX United States
- ALCYU
- Employees
- GNLX N/A
- ALCYU 3
- Industry
- GNLX Biotechnology: Pharmaceutical Preparations
- ALCYU
- Sector
- GNLX Health Care
- ALCYU
- Exchange
- GNLX Nasdaq
- ALCYU NYSE
- Market Cap
- GNLX 103.6M
- ALCYU N/A
- IPO Year
- GNLX 2023
- ALCYU N/A
- Fundamental
- Price
- GNLX $2.27
- ALCYU $10.98
- Analyst Decision
- GNLX Strong Buy
- ALCYU
- Analyst Count
- GNLX 4
- ALCYU 0
- Target Price
- GNLX $18.25
- ALCYU N/A
- AVG Volume (30 Days)
- GNLX 141.5K
- ALCYU N/A
- Earning Date
- GNLX 11-14-2024
- ALCYU N/A
- Dividend Yield
- GNLX N/A
- ALCYU N/A
- EPS Growth
- GNLX N/A
- ALCYU N/A
- EPS
- GNLX N/A
- ALCYU N/A
- Revenue
- GNLX $8,000.00
- ALCYU N/A
- Revenue This Year
- GNLX N/A
- ALCYU N/A
- Revenue Next Year
- GNLX N/A
- ALCYU N/A
- P/E Ratio
- GNLX N/A
- ALCYU N/A
- Revenue Growth
- GNLX N/A
- ALCYU N/A
- 52 Week Low
- GNLX $1.60
- ALCYU N/A
- 52 Week High
- GNLX $16.60
- ALCYU N/A
- Technical
- Relative Strength Index (RSI)
- GNLX 38.68
- ALCYU 46.01
- Support Level
- GNLX $2.13
- ALCYU $11.07
- Resistance Level
- GNLX $2.80
- ALCYU $11.10
- Average True Range (ATR)
- GNLX 0.20
- ALCYU 0.00
- MACD
- GNLX -0.04
- ALCYU -0.00
- Stochastic Oscillator
- GNLX 14.21
- ALCYU 0.00
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.
About ALCYU ALCHEMY INVTS ACQUISITION CORP 1 UNIT 1 CL A COM & 1/2 WT
Alchemy Investments Acquisition Corp 1 is a blank check company.